Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0001718996-24-000001·BriaCell Therapeutics Corp.
Schedule 13G ownership disclosure
BRIACELL THERAPEUTICS CORP
COMMON STOCK · CUSIP: 107930109
Event date: 2023-12-29
- Filing-level shares
- 818,375.00
- Percent of class
- 5.1%
- Copia Fund (Cayman) LP
Shares: 818,375.00 · Class: 5.1%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001718996-24-000001
- Form type
- SCHEDULE 13G
- Filer
- BriaCell Therapeutics Corp.
- CIK
- CIK 1610820
- Filed
- Jan 08, 2024
- Reporting period
- Dec 29, 2023
- Description
- Schedule 13G beneficial ownership